Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 39,411 | 30,594 | 27,404 | 20,469 | 5,009 |
| Cost of Goods | 15,317 | 13,127 | 15,570 | 11,640 | 6,206 |
| Gross Profit | 24,094 | 17,467 | 11,834 | 8,829 | -1,197 |
| Operating Expenses | 65,946 | 56,648 | 47,284 | 31,360 | 22,872 |
| Operating Income | -41,535 | -39,054 | -34,880 | -21,891 | -23,863 |
| Interest Expense | 880 | 20 | 19 | 90 | 95 |
| Other Income | 258 | 238 | 1,300 | 26 | 40 |
| Pre-tax Income | -42,157 | -38,836 | -33,599 | -21,955 | -23,918 |
| Income Tax | 40 | -573 | 44 | 148 | 52 |
| Net Income Continuous | -42,197 | -38,263 | -33,643 | -22,103 | -23,970 |
| Net Income | $-42,197 | $-38,263 | $-33,643 | $-22,103 | $-23,970 |
| EPS Basic Total Ops | -1.00 | -0.93 | -0.95 | -0.84 | -1.45 |
| EPS Basic Continuous Ops | -1.00 | -0.93 | -0.95 | -0.84 | -1.45 |
| EPS Diluted Total Ops | -1.00 | -0.93 | -0.95 | -0.84 | -1.45 |
| EPS Diluted Continuous Ops | -1.00 | -0.93 | -0.95 | -0.84 | -1.45 |
| EPS Diluted Before Non-Recurring Items | -1.00 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-37,665 | $-35,696 | $-32,036 | $-20,693 | $-22,537 |